MAS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Masco is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has supportive signals from analyst upgrades, bullish moving averages, and a positive congress purchase, but the current setup is stretched: RSI is deeply overbought, insider selling has surged, and the latest news points to limited organic growth ahead. Since you are impatient and want a direct answer, the better call is to hold off rather than buy immediately.
MAS is in a short-term uptrend with SMA_5 > SMA_20 > SMA_200 and a positive MACD histogram, showing bullish momentum. However, RSI_6 at 87.147 is strongly overbought, which suggests the recent move may be extended. Price at 82.59 is near the resistance zone around R1 82.131 and below R2 84.497, so upside from here looks limited in the near term. The stock trend data also suggests mixed follow-through, with a negative next-day/next-month bias despite modest weekly strength.
Analysts broadly raised price targets after a solid Q1 beat, with Truist, UBS, Wells Fargo, BMO, JPMorgan, RBC, Citi, Barclays, Baird, and BofA all updating views. Several firms highlighted strong Plumbing pricing, volume inflection, and cost execution. Congress trading data is also mildly supportive, with one recent purchase and no sales. The options market is leaning bullish, and the current moving-average structure supports momentum continuation.
The latest news says Masco has shown no organic revenue growth over the past two years, and projected sales growth is only 1.7% over the next 12 months. Insider selling has increased sharply, up 1883.12% over the last month, which is a clear negative signal. Analyst views are still mixed overall, with several Neutral/Market Perform/Equal Weight/Underperform ratings and caution around second-half margins, raw material inflation, tariffs, and limited top-line growth. The stock is also technically overbought.
Latest quarter: Q1. Financial commentary shows a solid earnings beat with pricing and cost gains outpacing tariff-related inflation. Analysts noted resilient volumes in Plumbing and stronger Pro Paint, but weak DIY Paint and rising raw material costs remain concerns. Guidance was not meaningfully raised, so the quarter looked good on execution but not on accelerating revenue growth.
Recent analyst trend is mostly positive on target changes but mixed on ratings. Price targets were generally raised across the Street, including JPMorgan to $78, BMO to $77, Truist to $90, RBC to $72, UBS to $97, Citi to $79, Wells Fargo to $82, Barclays to $78, and Baird to $80. However, ratings remain split: Neutral/Market Perform/Equal Weight/Underperform still dominate several firms, while the more bullish camps point to Q1 strength and execution. Overall Wall Street view is cautiously constructive, but not uniformly bullish.
